Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Condylomata Acuminata 9Uterine Cervical Neoplasms 7Vulvar Neoplasms 2Vaginal Neoplasms 2Papillomavirus Infections 2Uterine Cervical Dysplasia 1Penile Neoplasms 1Anus Neoplasms 1

Interventions

Radiotherapy 5Mitomycin 5Fluorouracil 5Watchful Waiting 3Paclitaxel 3Nivolumab 3Cisplatin 3Vaccines 2Radiation 2Observation 2Light Coagulation 2Carboplatin 2Capecitabine 2pembrolizumab 1nanocis 1cemiplimab 1atezolizumab 1X-Rays 1Vaccines, Synthetic 1Technetium-99 1Taxes 1Specimen Handling 1Sigmoidoscopy 1Proctoscopy 1Phantoms, Imaging 1Papillomavirus Vaccines 1Octreotide 1Neoadjuvant Therapy 1Mitomycins 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Anus Neoplasms × Vaccines, Synthetic × Clear all
NCT06465914 2024-12-12

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Shanghai Bovax Biotechnology Co., Ltd.

Phase 3 Active not recruiting
9,000 enrolled
GastrointestinalGenitourinary

Anus Neoplasms, Condylomata Acuminata, Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡